influenza
viru
one
common
season
respiratori
virus
affect
human
lead
death
everi
year
pandem
viru
viru
estim
caus
respiratori
death
first
month
death
occur
patient
age
year
avian
influenza
virus
togeth
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
coronavirus
virul
respiratori
virus
affect
human
patient
influenza
viru
infect
develop
mild
upper
respiratori
tract
infect
lifethreaten
complic
includ
sever
viral
pneumonia
secondari
bacteri
pneumonia
acut
respiratori
distress
syndrom
pulmonari
embol
myocard
encephalopathi
rey
syndrom
hemophagocyt
syndrom
multiorgan
dysfunct
exacerb
underli
chronic
cardiovascular
respiratori
diseas
current
avail
antivir
vaccin
limit
efficaci
treatment
prevent
influenza
viru
infect
understand
pathogenesi
influenza
viru
infect
human
import
design
novel
strategi
improv
manag
influenza
caus
infect
influenza
viru
need
evad
host
immun
enter
replic
insid
host
cell
dissemin
cell
organ
host
damag
result
direct
virusinduc
damag
immunemedi
damag
andor
secondari
bacteri
infect
virologist
extens
studi
role
viral
compon
viral
life
cycl
pathogenesi
influenza
viru
infect
human
specif
amino
acid
chang
viral
protein
associ
increas
diseas
sever
human
adapt
avian
influenza
virus
human
clinic
risk
factor
sever
influenza
well
describ
figur
howev
specif
human
gene
regul
influenza
viru
life
cycl
virusinduc
inflammatori
respons
less
well
describ
tradit
studi
host
gene
depend
prior
knowledg
candid
gene
import
candid
gene
verifi
use
singl
gene
knockout
knockdown
gainoffunct
studi
revers
genet
vitro
vivo
exampl
chines
japanes
patient
influenzaassoci
encephalopathi
iae
found
elev
acylcarnitin
ratio
carnitin
palmitoyltransferas
variant
found
overrepres
iae
patient
compar
gener
popul
mutat
render
enzym
suscept
inactiv
high
temperatur
occur
febril
patient
highthroughput
screen
platform
allow
research
systemat
screen
larg
number
gene
associ
influenza
viru
infect
vitro
anim
human
avail
deep
sequenc
data
human
genom
allow
research
compar
genet
variat
influenza
patient
gener
popul
technolog
advanc
combin
vitro
bioinformat
analysi
reveal
sever
gene
associ
sever
influenza
figur
tabl
review
focu
specif
host
gene
shown
directli
relat
pathogenesi
human
influenza
identifi
updat
knowledg
past
year
four
type
surfact
protein
found
human
pulmonari
surfact
surfact
protein
surfact
protein
sftpd
collectin
exhibit
antivir
activ
influenza
viru
variant
haplotyp
associ
sever
respiratori
deterior
surfact
protein
b
sftpb
hydrophob
protein
respons
structur
integr
pulmonari
alveoli
cohort
chines
patient
sever
mild
infect
match
age
sex
underli
condit
snp
significantli
associ
sever
diseas
associ
sever
diseas
verifi
second
cohort
patient
infect
multivari
analysi
perform
adjust
potenti
confound
factor
snp
associ
glycosyl
amino
acid
residu
sftpb
reduc
secret
sftpb
remain
determin
whether
sftpb
direct
antivir
activ
influenza
viru
surfact
protein
c
sftpc
lipoprotein
antivir
activ
respiratori
syncyti
viru
antivir
activ
influenza
viru
genet
variant
associ
sever
influenza
yet
report
lectin
galactosidebind
solubl
also
known
galectin
bind
influenza
virus
inhibit
viral
replic
carriag
haplotyp
gg
associ
protect
viru
infect
human
furthermor
haplotyp
gg
correl
higher
level
mrna
protein
express
lymphoblast
cell
line
therefor
differenti
express
may
contribut
distinct
suscept
individu
human
influenza
upon
influenza
viru
infect
type
interferon
produc
host
cell
limit
viral
replic
host
factor
age
pregnanc
obes
underli
condit
preexist
level
immun
genet
suscept
function
type
interferon
mediat
via
express
mani
interferon
stimul
gene
isg
sever
isg
especi
import
pathogenesi
influenza
viru
infect
interferoninduc
transmembran
protein
ifitm
includ
identifi
direct
antivir
activ
influenza
viru
genomewid
sirna
screen
human
long
noncod
rna
reduc
gene
express
enhanc
influenza
viru
replic
transgen
mous
model
locat
endosom
inhibit
viral
replic
block
fusion
viral
host
membran
interestingli
amphotericin
b
antifung
found
increas
viral
replic
interf
blockag
membran
fusion
cc
genotyp
associ
truncat
ntermin
protein
alter
local
endosom
compart
cell
peripheri
sever
studi
look
snp
suscept
sever
influenza
human
genotyp
overrepres
caucasian
chines
patient
sever
viru
infect
patient
infect
carri
genotyp
higher
mortal
howev
import
allel
sever
influenza
challeng
firstli
studi
use
pseudotyp
influenza
virus
transfect
cell
plasmid
express
truncat
form
could
reduc
viral
replic
similarli
plasmid
carri
full
length
secondli
studi
compar
patient
sever
viru
infect
control
signific
differ
genotyp
frequenc
found
interferon
regulatori
factor
transcript
factor
regul
express
type
interferon
influenza
viru
replic
high
titer
madindarbi
canin
kidney
cell
knockdown
gene
murin
tracheal
epitheli
cell
defici
impair
express
interferon
influenza
viru
infect
studi
compar
genet
variant
healthi
individu
snp
host
gene
influenza
pathogenesi
et
al
host
genet
determin
influenza
viru
diseas
sever
identifi
human
host
gene
associ
sever
influenza
highlight
red
found
associ
induct
antivir
gene
dendrit
cell
respons
influenza
viru
infect
girl
without
known
immunodefici
suffer
sever
influenza
viru
infect
mutat
identifi
use
whole
exom
sequenc
induct
type
type
iii
interferon
gene
dendrit
cell
pulmonari
epitheli
cell
found
impair
girl
posttransl
cleavag
influenza
viru
hemagglutinin
host
proteas
prerequisit
virushost
membran
fusion
therebi
viru
infect
tissu
tropism
viru
pathogen
transmembran
proteas
serin
type
ii
transmembran
serin
proteas
cleav
activ
viral
hemagglutinin
influenza
viru
infect
three
independ
studi
assess
role
influenzainfect
mice
knockout
mice
resist
influenza
viru
infect
discrep
result
regard
suscept
viru
infect
integr
pilot
genomewid
associ
studi
lung
express
quantit
trait
loci
eqtl
dataset
intron
snp
priorit
studi
genet
predisposit
sever
valid
patient
includ
sever
case
mild
control
function
studi
regulatori
snp
high
linkag
disequilibrium
uncov
causal
variant
underli
genet
associ
genet
predisposit
sever
influenza
also
valid
patient
cohort
isg
encod
plasminogen
activ
inhibitor
cell
overexpress
inhibit
spread
influenza
viru
compar
cell
without
overexpress
inhibit
extracellular
cleavag
hemagglutinin
knockout
mice
higher
viral
titer
sever
diseas
wild
type
mice
human
fibroblast
cell
line
deriv
patient
carri
allel
result
intracellular
retent
influenza
viru
replic
enhanc
compar
infect
cell
line
deriv
patient
carri
genotyp
cytokin
import
defens
influenza
viru
infect
howev
excess
cytokin
respons
associ
sever
influenza
tumor
necrosi
factora
tnfa
consid
proinflammatori
cytokin
treatment
antitnfa
improv
surviv
infect
mice
howev
tnfknockout
mice
sever
diseas
furthermor
solubl
form
tnfa
shown
requir
control
cell
respons
suggest
tnfa
requir
control
infect
network
base
approach
combin
mous
human
vitro
data
show
tnf
pathway
import
influenza
viru
infect
allel
associ
sever
influenza
studi
compar
patient
healthi
control
howev
associ
found
anoth
studi
compar
fatal
case
gener
popul
persist
elev
patient
sever
influenza
viru
infect
knockout
mice
shown
rapid
viral
clearanc
improv
surviv
blockag
could
amelior
inflamm
influenzaviru
infect
human
pulmonari
endotheli
cell
lung
fibroblast
allel
aa
genotyp
associ
sever
diseas
anoth
studi
involv
patient
viru
infect
healthi
control
gene
associ
suscept
infect
howev
associ
snp
gene
influenza
viru
diseas
sever
base
singl
cohort
studi
necessari
confirm
signific
polymorph
influenza
interact
host
antibodi
fc
region
fc
receptor
import
immun
defens
influenza
viru
infect
fc
fragment
igg
low
affin
iia
receptor
gene
encod
fcg
receptor
iia
fcgriia
bind
immun
complex
associ
polymorph
sever
viru
infect
first
identifi
european
cohort
although
associ
found
chines
cohort
fcgriia
signal
found
import
immun
complexmedi
platelet
activ
influenza
viru
infect
interestingli
recent
studi
broadli
neutral
antibodi
influenza
virus
abil
form
immun
complex
interact
fc
region
antibodi
fcg
receptor
may
mediat
antibodydepend
cellular
cytotox
import
vivo
efficaci
antibodi
major
sensor
viral
doubl
strand
rna
mutat
found
associ
influenzaassoci
encephalopathi
snp
genotyp
associ
patient
pneumonia
import
subsequ
confirm
knockout
mice
studi
futur
studi
host
gene
human
review
summar
host
gene
shown
import
pathogenesi
influenza
human
highthroughput
assay
larg
number
gene
genet
variant
found
associ
viral
replic
diseas
sever
anim
human
current
challeng
select
specif
host
gene
import
treatment
prevent
influenza
viru
infect
discrep
result
similar
studi
also
rais
suspicion
whether
certain
gene
inde
import
exampl
host
factor
affect
influenza
viru
replic
identifi
vitro
genomewid
sirna
knockdown
screen
gene
present
least
two
screen
human
genet
associ
studi
mani
genet
variant
identifi
associ
diseas
sever
one
studi
could
reproduc
studi
tabl
sever
strategi
use
improv
abil
find
gene
relev
influenza
pathogenesi
human
human
genet
associ
studi
import
limit
confound
factor
much
possibl
exampl
case
control
match
age
sex
ethnic
group
comorbid
multivari
analysi
util
assess
whether
genet
variant
independ
risk
factor
identifi
genet
variant
valid
independ
cohort
function
signific
genet
variant
refin
eqtl
analysi
pathway
analysi
help
identifi
pathway
may
appar
analyz
individu
gene
interactom
screen
identifi
host
gene
interact
viral
protein
may
increas
likelihood
identifi
gene
potenti
host
target
treatment
establish
genet
divers
mice
popul
allow
identif
suscept
gene
correl
genet
variat
diseas
phenotyp
addit
genet
data
host
respons
influenza
also
assess
use
transcriptom
proteom
metabolom
lipidom
analysi
cell
cultur
anim
human
data
reflect
biolog
regul
host
factor
differ
level
integr
omic
data
improv
accuraci
identifi
suscept
gene
although
studi
identifi
sever
genet
polymorph
gene
predispos
sever
influenza
possibl
suscept
individu
may
differ
suscept
gene
combin
futur
possibl
whole
genom
sequenc
allow
accur
identif
suscept
gene
combin
particular
individu
figur
addit
compar
sever
mild
influenza
case
anoth
approach
identifi
host
suscept
gene
examin
patient
resist
influenza
viru
infect
studi
patient
congenit
disord
glycosyl
without
serolog
evid
influenza
viru
infect
viru
product
found
macrophag
cultur
deriv
patient
author
studi
postul
lack
glycosyl
viral
surfac
protein
may
affect
viru
product
understand
role
host
factor
viru
infect
led
hosttarget
antivir
remov
sialicacid
contain
receptor
respiratori
epitheli
cell
prevent
viru
attach
host
cell
phase
ii
clinic
trial
shown
reduc
nasal
pharyng
viral
load
influenza
patient
antivir
antiinflammatori
agent
target
host
factor
vaccin
strategi
improv
host
respons
shown
promis
anim
model
exampl
agonist
protectin
antileptin
antibodi
shown
protect
mice
lethal
influenza
viru
infect
imiquimod
agonist
shown
expedit
augment
antibodi
respons
influenza
viru
vaccin
anim
human
studi
integr
vitro
anim
clinic
data
allow
research
engin
viral
resist
